Evidence map›Paper›PMID 40143726›Full record

ArticlePsychiatry investigation2025

Smoking Susceptibility and Anti-Smoking Awareness in Adolescents and Young Adults of Bangladesh.

Mohd Ashik Shahrier, Seockhoon Chung

Abstract read
In one paragraph

Article in Psychiatry investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohd Ashik ShahrierDepartment of Psychology, Faculty of Biological Sciences, University of Rajshahi, Rajshahi, Bangladesh.
Seockhoon ChungDepartment of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe present study addressed the shortcomings of strictly defined criterion and survey-based approaches of previous smoking susceptibility measures and accordingly, developed and validated two scales, Smoking Susceptibility Measure (SSM) and Anti-Smoking Awareness Scale (ASAS).

methodsFirstly, the generation of SSM and ASAS items followed an extensive literature review, expert opinions and agreement, resulting in the retention of eight items for SSM and seven items for ASAS to administer them on a large sample (n=312). Average inter-item correlations, corrected item-total correlations, and internal consistency reliabilities of the measures fall within the recommended ranges. The data were found suitable to factorize the sample through exploratory factor analysis. To determine the structural validity of the measures, confirmatory factor analysis (CFA) was done, and the data had an adequate model fit for unifactorial solution. Multi-group CFA revealed that both measures can be applied in the same way across age and sex of the participants.

resultsAn inverse association of school connectedness with smoking susceptibility and positive association with anti-smoking awareness reflected the convergent validity of the measures. Hierarchical regression analysis showed that smoking susceptivity was negatively predicted by anti-smoking awareness and school connectedness whereas, positively predicted by self-esteem of the participants.

conclusionThe SSM and ASAS were found to be psychometrically sound tools to objectively measure never-smoking youths' smoking susceptibility and anti-smoking awareness, targeting effective intervention strategies to prevent adolescents and young adults from being a regular smoker.

Indexed as

AdolescentsAnti-smoking awarenessSmoking susceptibilityValidation.Young adults

Identifiers

PMID40143726
PMCPMC11962528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.